Kirsten Wentlandt

Kirsten Wentlandt

Auto-generated profile, based on publicly available information

Kirsten Wentlandt

Division of Palliative Care, Department of Family and Community Medicine, University of Toronto, Toronto

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
Joel KatzJoel Katz
Joel Katz
AWAliza Weinrib
Aliza Weinrib
SFSamantha R Fashler
Samantha R Fashler
RKRita Katznelson
Rita Katznelson
BSBansi R Shah
Bansi R Shah
HCHance Clarke
Hance Clarke
Chronic postsurgical pain (CPSP), an often unanticipated result of necessary and even life-saving procedures, develops in 5–10% of patients one-year after major surgery. Substantial advances have been made in identifying patients at elevated risk of developing CPSP based on perioperative pain, opioid use, and negative affect, including depression, anxiety, pain catastrophizing, and posttraumatic stress disorder-like symptoms. The Transitional Pain Service (TPS) at Toronto General Hospital (TGH) is the first to comprehensively address the problem of CPSP at three stages: 1) preoperatively, 2) postoperatively in hospital, and 3) postoperatively in an outpatient setting for up to 6 months after surgery. Patients at high risk for CPSP are identified early and offered coordinated and comprehensive care by the multidisciplinary team consisting of pain physicians, advanced practice nurses, psychologists, and physiotherapists. Access to expert intervention through the Transitional Pain Service bypasses typically long wait times for surgical patients to be referred and seen in chronic pain clinics. This affords the opportunity to impact patients' pain trajectories, preventing the transition from acute to chronic pain, and reducing suffering, disability, and health care costs. In this report, we describe the workings of the Transitional Pain Service at Toronto General Hospital, including the clinical algorithm used to identify patients, and clinical services offered to patients as they transition through the stages of surgical recovery. We describe the role of the psychological treatment, which draws on innovations in Acceptance and Commitment Therapy that allow for brief and effective behavioral interventions to be applied transdiagnostically and preventatively. Finally, we describe our vision for future growth.

10 December 2012 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
KWKirsten Wentlandt
Kirsten Wentlandt
MKMonika K Krzyzanowska
Monika K Krzyzanowska
NSNadia Swami
Nadia Swami
GRGary Rodin
Gary Rodin
LLLisa W. Le
Lisa W. Le
Camilla ZimmermannCamilla Zimmermann
Camilla Zimmermann
Purpose: To describe current referral practices of oncologists to specialized palliative care (SPC) and define demographic characteristics, practice situations, and opinions associated with referral. Methods: Physician members of the Canadian Association of Medical Oncologists, Canadian Association of Radiation Oncologists, and Canadian Society of Surgical Oncology were invited to participate in an anonymous survey assessing SPC referral practices. Participants received two e-mailed and two mailed invitations. Results: The response rate was 72% (603 of 839 physicians); 37% were medical oncologists/hematologists, 50% were radiation oncologists, and 12% were surgical oncologists. Ninety-four percent reported that SPC was available to them, but only 37% reported that these services accepted patients on chemotherapy. Eighty-four percent referred terminally ill patients usually/always, but generally for uncontrolled symptoms or discharge planning late in the disease course. One third would refer to SPC earlier if it was renamed supportive care. Predictors of higher referral frequency included comprehensiveness of available SPC services (P = .004), satisfaction with SPC availability (P < .001), SPC acceptance of patients receiving chemotherapy (P < .001), and oncologist ease with referring patients to a palliative care service before they were close to death (P < .001). Controlling for specialty, predictors of referral at diagnosis or during chemotherapy, rather than later, included satisfaction with SPC service availability (P < .001) and SPC service acceptance of patients on chemotherapy (P < .001). Conclusion: Oncologists referred patients frequently to SPC, but generally late in the disease course for patients with uncontrolled symptoms. Availability of comprehensive SPC, especially for patients receiving chemotherapy, and persisting definitional issues seem to be the main barriers preventing timely referral.

1 October 2002 in Journal of Neurophysiology
Verified
Journal Article
Open access
PDF file
SJShokrollah S. Jahromi
Shokrollah S. Jahromi
KWKirsten Wentlandt
Kirsten Wentlandt
SPSanaz Piran
Sanaz Piran
PCPeter Carlen
Peter Carlen
Gap junctions (gjs) are increasingly recognized as playing a significant role in seizures. We demonstrate that different types of gap junctional blocking agents reduce the duration of evoked seizure-like primary afterdischarges (PADs) in the rat in vitro CA1 hippocampal pyramidal region, following repetitive tetanization of the Schaffer collaterals. Intracellular acidosis, which is known to block gap junctional communication, decreased the PADs, whereas alkalinization increased the PADs. Cellular excitability was not significantly depressed as determined by input/output relations recorded before and during perfusion of the gj blockers blockers carbenoxolone and sodium propionate. There was a small decrease following 1-octanol perfusion and a large decrease following NH4Cl application. Carbenoxolone diminished PAD duration, but increased neuronal excitability in whole-cell recordings. After robust PADs were established, the expression of several gj proteins including connexins (Cxs) 26, 32, 36, and 43, as measured by Western blotting, was unchanged, although the level of nonphosphorylated Cx43 was decreased. Our data support the concept that blocking gap junctional communication is an anticonvulsant mechanism.

1 April 2008 in Experimental Neurology
Verified
Journal Article
Closed access
MSMarina Samoilova
Marina Samoilova
KWKirsten Wentlandt
Kirsten Wentlandt
YAYana Adamchik
Yana Adamchik
AVAlexander A. Velumian
Alexander A. Velumian
PCPeter Carlen
Peter Carlen

10 March 2015 in Drugs
Verified
Journal Article
Closed access
PDF file
HCHance Clarke
Hance Clarke
MPMichael Poon
Michael Poon
AWAliza Weinrib
Aliza Weinrib
RKRita Katznelson
Rita Katznelson
KWKirsten Wentlandt
Kirsten Wentlandt
Joel KatzJoel Katz
Joel Katz

4 July 2003 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
MSMarina Samoilova
Marina Samoilova
JLJianxue Li
Jianxue Li
MPMarc R. Pelletier
Marc R. Pelletier
KWKirsten Wentlandt
Kirsten Wentlandt
YAYana Adamchik
Yana Adamchik
PCPeter Carlen
Peter Carlen
Chronic (18 h) exposure of cultured hippocampal slices to the type‐A GABA receptor blocker, bicuculline methiodide (BMI) 10 μm increased the levels of connexin 43 (Cx43) and connexin 32 (Cx32) mRNAs, but not connexin 26 and connexin 36, as demonstrated by RNase protection assays. The levels of Cx43 and Cx32 proteins in membrane fractions detected by western blotting were also significantly increased. Immunoblotting indicated that BMI also promoted a significant expression of the transcription protein c‐fos. The rate of fluorescence recovery after photobleaching, an index of gap junctional coupling, was also significantly increased, whereas it was blocked by the gap junctional blocker, carbenoxolone (100 μm). Extracellular recordings in CA1 stratum pyramidale, performed in BMI‐free solution, demonstrated that BMI‐exposed cultures possessed synaptic responses characteristic of epileptiform discharges: (i) significantly greater frequency of spontaneous epileptiform discharges, (ii) post‐synaptic potentials with multiple population spikes, and (iii) significantly longer duration of primary afterdischarges. Carbenoxolone (100 μm), but not its inactive analog, oleanolic acid (100 μm), reversibly inhibited spontaneous and evoked epileptiform discharges. The findings of BMI‐induced parallel increases in levels of gap junction expression and function, and the increase in epileptiform discharges, which were sensitive to gap junctional blockers, are consistent with the hypothesis that increased gap junctional communication plays an intrinsic role in the epileptogenic process.